Liver diseases affect millions of people worldwide. In most developed countries, the
incidence of viral hepatitis is waning as a result of modern advances in disease prevention …

During the last forty years we have witnessed impressive advances in the field of antiviral
drug discovery culminating with the introduction of therapies able to stop human …

Effective treatments for coronavirus disease 2019 (COVID-19) are urgently needed to control
this current pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS …

Web Annexes Page 1 Page | i GUIDELINES ON HEPATITIS B AND C TESTING February 2017
GUIDELINES ANNEXES Page 2 Page | ii WHO guidelines on hepatitis B and C testing ISBN …

Hepatitis C virus (HCV) drug development has resulted in treatment regimens composed of
interferon‐free, all‐oral combinations of direct‐acting antivirals. While the new regimens are …

Summary Background Hepatitis C virus (HCV) genotype 4 accounts for about 13% of global
HCV infections. Because interferon-containing treatments for genotype 4 infection have low …

There has been a revolution in the treatment of chronic hepatitis C. Several oral regimens
combining direct‐acting antivirals (DAA s) from different families [NS 5B nucleotide …

Chronic hepatitis C virus (HCV) infection is a leading cause of chronic liver disease. The
introduction of direct acting antiviral agents (DAAs) for its treatment represents a major …

Liver transplantation (LT) in Europe became an established life-saving treatment for patients
with end-stage liver disease, hepatocellular carcinoma, and acute liver conditions with life …

Cancer burden worldwide is projected to rise from 14 million new cases in 2012 to 24 million
in 2035. Although the greatest increases will be in develo** countries, where cancer …